Clinical trial
A Phase II Study of M6620 (VX-970) in Selected Solid Tumors
NCT03718091 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of M6620 (VX-970) in Selected Solid Tumors
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 8, 2019
- Completion date
- July 8, 2020
- Enrollment
- 30 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
leiomyosarcoma, osteosarcoma, solid tumor